Home » News

News


EventCalendar

  • The 5th IVI International Congress: Reproductive Medicine and Beyond by ComtecMed
    04-Apr-13 to 06-Apr-13 Seville , SPAIN (GYN - Contraception & Reproductive Health)
     
  • 2013 AIUM Annual Convention by American Institute of Ultrasound in Medicine
    06-Apr-13 to 10-Apr-13 New York (New York Marriott Marquis Hotel) , NY USA (CME - Medical Education)
     
  • Manejo clínico y terapéutico de la esterilidad. Segundo curso online by Fundacio Dexeus Salud de la Mujer
    09-Apr-13 to 31-May-13 online , SPAIN(gynecology)
     
  • Pediatric Nursing: Care of the Hospitalized Child by Continuing Education Inc.
    10-Apr-13 to 13-Apr-13 Anaheim (Hyatt Regency Orange County) , CA USA (CME - Obstetrics, Gynecology & Women's Health)
     
  • Medicina fetal Curso-Taller. Curso de Nivel I y II de la SESEGO by Fundacio Dexeus Salud de la Mujer
    15-Apr-13 to 17-Apr-13 Barcelona (Auditorio Salud de la Mujer Dexeus) , SPAIN (OB - Maternal Fetal Medicine)
     
  • Female Urology & Urogynecology Symposium (FUUS) by Quadrant HealthCom, Inc
    18-Apr-13 to 20-Apr-13 Las Vegas (ARIA) , NV USA (CME - Obstetrics, Gynecology & Women's Health)
     
  • Female Urology and Urogynecology Symposium (FUUS) 2013 by Quadrant HealthCom, Inc
    18-Apr-13 to 20-Apr-13 Las Vegas (ARIA) , NV USA (CME - Obstetrics, Gynecology & Women's Health)

FeaturedContent


FDA Contraindicates Migraine Treatments for Pregnant Women
Rachel Warren , May 8, 2013

The US Food and Drug Administration has announced that the children of mothers who took medications including or related to valproate sodium during pregnancy show decreased IQ scores, and that these drugs are now contraindicated for pregnant women.

FDA Approves OTC Plan B for Women 15 Years and Up
Rachel Warren , May 1, 2013

The FDA has approved an application to market the emergency contraceptive Plan B One-Step for use without a prescription by women 15 years of age and older.

Findings Highlight Lone Intervention for Premature Rupture of Membranes
Jamie Habib , November 14, 2012

The findings of a new systematic review have shown that serial transabdominal amnioinfusion may decrease morbidity and mortality rates associated with preterm premature rupture of membranes.

IUD May Effectively Treat Early-Stage Endometrial Cancer
Jamie Habib , November 12, 2012

An intrauterine device (IUD) is an effective tool in the treatment of early-stage endometrial cancer in certain patients, according to the results of a small study presented at the International Gynecological Cancer Society’s 14th biennial meeting.

How to Improve Patient Safety with the Patient Handoff
Jamie L. Habib , March 6, 2012

Poor communication is a leading cause of medical errors in this era of collaborative care. Effective communication strategies can help facilitate the continuity of care, prevent errors, and provide a safe environment for the patient.

Differentiating Between IC/PBS and Bladder Oversensitivity
Heidi Anne Duerr, MPH , March 6, 2012

With common and overlapping symptoms and subjective patient reporting, interstitial cystitis/painful bladder syndrome (IC/PBS) and bladder oversensitivity can be difficult to distinguish, making diagnosis and treatment recommendations tricky.

Fluorochemical Exposure in Utero May Cause Obesity in Offspring
Heidi Anne Duerr, MPH , March 5, 2012

Modern society has witnessed great improvements in everyday products, often thanks to advances in chemical compounds that make products better, stronger, and the like. Unfortunately, these advances may come at a cost, as prenatal exposure to some chemical compounds may have deleterious effects on offspring.

How to Screen for Intimate Partner Violence: Tools from ACOG
Jamie L. Habib , February 29, 2012

More than one third of women in the United States will experience some form of intimate partner violence (IPV) in their lifetime. The consequences of IPV can be lifelong and include emotional trauma, long-term physical impairment, chronic health problems, and even death.

Stress Urinary Incontinence: What Treatment Works Best?
Heidi Anne Duerr, MPH , February 24, 2012

While tension-free vaginal tape (TVT) is and single-incision mini-sling result in similar subjective cure rates for the treatment of stress urinary incontinence, the mini-sling is still inferior, according to a randomized study published in Obstetrics & Gynecology.

Group CBT Relieves Menopause Symptoms After Breast Cancer
Heidi Anne Duerr, MPH , February 23, 2012

Group cognitive behavioral therapy (CBT) is an effective tool in reducing menopause-related symptoms in women with a history of breast cancer, according to new research published in The Lancet Oncology.

Vitamin D Important for Fetal Neurocognitive Development
Heidi Anne Duerr, MPH , February 22, 2012

Researchers have found that proper maternal serum 25(OH)-vitamin D concentrations are crucial to fetal development. Dr. Andrew J. O. Whitehouse, associate professor at the Telethon Institute for Child Health Research at the University of Western Australia, and colleagues published their work in a recent issue of Pediatrics.

Donor-Egg In Vitro Appears Safe for Older Women
Heidi Anne Duerr, MPH , February 17, 2012

Women over the age of 50 who achieve a viable pregnancy via donor-egg in vitro fertilization (D-IVF) have no greater incidence of adverse outcomes than younger women,according to a new study published in the American Journal of Perinatology.

Bipolar Radiofrequency Endometrial Ablation Outperforms Hydrothermablation for Menorrhagia
Heidi Anne Duerr, MPH , February 16, 2012

Bipolar radiofrequency endometrial ablation is more effective than hydrothermablation in the treatment of menorrhagia at five years, according to research published in Obstetrics & Gynecology.

Misoprostol May Be Effective Oxytocin Alternative
Heidi Anne Duerr, MPH , February 15, 2012

Misoprostol is a safe and effective alternative to titrated intravenous for addressing abnormalities of the active phase of labor, according to new research published in Obstetrics and Gynecology.

Ulipristal is Safe and Effective for Uterine Fibroids
Heidi Anne Duerr, MPH , February 10, 2012

Ulipristal is a safe and effective option for women with uterine fibroids, according to two new studies published in the New England Journal of Medicine. In both studies, the oral selective progesterone receptor modulator was well-tolerated, rapidly reduced excessive bleeding, and decreased the size of uterine fibroids.

Pre-pregnancy Dietary Changes May Reduce Gestational Diabetes Risk
Heidi Anne Duerr, MPH , February 9, 2012

A woman’s diet before pregnancy can affect her risk of developing gestational diabetes, according to researchers from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

Laparoscopy Acceptable for Staging Endometrial Cancer
Heidi Anne Duerr, MPH , February 7, 2012

Laparoscopic staging of uterine cancer is associated with only a small increased risk of recurrence, according to a new study in the Journal of Clinical Oncology.

Do Combined Oral Contraceptives Relieve Dysmenorrhea?
Heidi Anne Duerr, MPH , February 3, 2012

Oral contraceptives have long been considered an option for relieving symptoms of dysmenorrhea, but a 2009 Cochrane review cast doubt on that claim. Now, a new study out of Sweden offers contradictory evidence.

New Blood Test Reveals Fetus’s Gender Five Weeks after Conception
Heidi Anne Duerr, MPH , February 1, 2012

A new blood test may safely reveal the gender of a fetus in the first trimester, according to new research published in the Journal of the Federation of American Societies for Experimental Biology.

Midstream Testing Effectively Diagnoses Chlamydia Trachomatis
Heidi Anne Duerr, MPH , January 30, 2012

According to research published in the Annals of Family Medicine, midstream urine testing effectively detects Chlamydia trachomatis.

Requiring Pharma to Disclose Payments Paints Doctors as Villains
Richard Chudacoff, MD, FACOG , January 26, 2012

ObGyn.net blogger Richard Chudacoff, MD, FACOG, responds to the news that new health care laws will require pharmaceutical companies to disclose all payments to doctors.

SSRI Use in Pregnancy May Double Infant’s Risk of Pulmonary Hypertension
Heidi Anne Duerr, MPH , January 24, 2012

Persistent pulmonary hypertension, which affects as many as 2 per 1,000 liveborn infants, is a life-threatening condition. While there are many risk factors, research has linked the use of selective serotonin reuptake inhibitors (SSRIs) in late pregnancy with increased risk for persistent pulmonary hypertension.

The Link Between Parabens and Breast Cancer: How Much Worry Is Warranted?
Heidi Anne Duerr, MPH , January 20, 2012

Over the past few years, there has been great concern over the presence of alkyl esters of p-hydroxybenzoic acid (parabens) in consumer products and their link to breast cancer. These compounds have been found in human blood, milk, urine, and breast tissue.

New Concern About Statin Use in Postmenopausal Women: New-Onset Diabetes
Heidi Anne Duerr, MPH , January 18, 2012

Statin use in postmenopausal women is associated with an increased risk of new-onset diabetes mellitus, according to a new study published in the Archives of Internal Medicine.

When Counting Counts: Maternal Fetal Movement Counts Improve Fetal Distress Recognition
Heidi Anne Duerr, MPH , January 17, 2012

Fetal movement counts, a simple, inexpensive, and easily accessible tool a pregnant mother can use to help monitor the wellbeing of her fetus, have been used to identify potential problems in a timely manner, allowing for prompt interventions. However, the practice has been disputed among health care professionals for lack of conclusive evidence that counting reduces perinatal morbidity and mortality. Now, new research shows that counting has a positive impact.

Antiestrogen Therapy May Prevent Melanoma in Patients with Breast Cancer
Heidi Anne Duerr, MPH , January 13, 2012

Findings published in the latest issue of Cancer Prevention Research suggest that antiestrogen supplements help decrease the risk of subsequent melanoma in patients with breast cancer.

Genital Herpes Vaccine Not Ready for Prime Time
Heidi Anne Duerr, MPH , January 12, 2012

Although previous studies of a new genital herpes vaccine were encouraging, it failed to protect women in a recent large clinical trial.

Addition of Bevacizumab to Ovarian Cancer Treatment is Associated With Better Survival
Heidi Anne Duerr, MPH , January 8, 2012

Two new studies published in the New England Journal of Medicine point to the importance of using bevacizumab in the treatment of ovarian cancer. Bevacizumab, a recombinant humanized monoclonal antibody directed against the vascular endothelial growth factor, has shown single-agent activity in women with recurrent tumors.

Impaired Uterine Contractility Associated With Diabetes
Heidi Anne Duerr, MPH , January 6, 2012

Women with diabetes can bring a host of medical complications to their pregnancy. Recently, research has shown that cesarean section rates are higher in women with diabetes, and some estimates note that more than half of those C-sections are emergency operations and not elective procedures.

Foley Catheter is a Safe, Effective Option for Labor Induction
Heidi Anne Duerr, MPH , January 4, 2012

Foley catheter or vaginal prostaglandin E2 gel—which is the better option for induction in pregnant women with unfavorable cervix at term? According to new research, the Foley catheter may be a better choice.


MedicaForum

Medica Forums - 6/17/13
First, Plan B was only available OTC to women age 17 and up. In April, a judge ordered that it be made available to women of all ages. Now, an appeals court judge has stayed an order that would make a one-dose version of the emergency contraception available to all ages, while allowing the two-dose drug to be sold OTC without restriction. What do you make of all this?
Medica Forums - 6/15/13
muscle pain relief in Hong kong
eToims is a non-invasive pain therapy treatment for individuals desiring general physical health maintenance and enhancement or relief from chronic pain.Back pain is often caused or aggravated by bad or worn-out mattresses. A new pressure-relieving mattress and pillow can make a huge difference. It can support your back, shoulders and neck where it needs it most and thereby help you sleep in a better position, relieving pressure points and back pain. For more information on pressure relieving mattresses and pillows click here.For more information visit us at- Email-info@etoims.com,Contact- +1 215-387-0550.
Medica Forums - 6/12/13
For the past few months, I have not received any posts on the listserv OB-GYN-L. I would get daily posts in my e-mail. Where has it gone, what has happened to it? What can I do to get back on the list?

If anybody has any information, send me a note at:

dean@thehuffpeople.net


Dean Huffman
Medica Forums - 6/6/13
Pregnant woman and the newborn infant in breast feeding both of them need safety. So, caution in use of drugs in pregnancy and during lactation is mandatory. The knowledge of risk-benefit ratio of different drugs should be in mind of the doctor while prescribing a pregnant or lactating lady.Definitions of Pregnancy categories of drugs and a table showing pregnancy categories of drugs and safety of drugs in lactation are given here.

Definitions of Pregnancy categories of drugs:

On the basis of the potentiality for producing birth defects drugs in pregnancy are grouped into 1 of 5 categories which are A,B, C, D and X. Drugs of class A and B are considered safe and can be used routinely.

Pregnancy Category A : Controlled studies in pregnant women fail to detect risk to the fetus in the first trimester and no evidence of risk in later trimesters. The possibility of harm to the fetus appears remote by using the drugs of pregnancy category A.

Pregnancy Category B : Presumed safety on the basis of animal studies, with no controlled study in pregnant women, or animal studies have shown an adverse effect which was not confirmed in controlled studies in women in the first trimester and there is no evidence of risk to the fetus in later trimesters.

Pregnancy Category C : Studies in women and animals are not available or studies in animals have shown adverse effects on the fetus and there is no controlled study in women. Drugs should be given in pregnancy only if the potential benefits justify the potential risk to the fetus.

Pregnancy Category D : There is positive evidence of risk to the human fetus (unsafe), however in a life-threatening illness the potential risk may be justified if there are no other alternatives.

Pregnancy Category X : Highly unsafe: risk of use outweighs any potential benefit. Drugs in this category are contraindicated in pregnant women or in a woman who may become pregnant. To get more please visit -
http://medicalforall.net/drugs-pregnancy-lactation/
Medica Forums - 6/1/13
Recently, I had the occasion to review a case of a term primigravida with PROM in a private hospital (no housestaff or in house obstetricians). She was seen by an obstetrician soon after arrival, evaluated, and pitocin induction begun.

She did not deliver for around 29 hours after admission, and the delivering obstetrician (a different physician) was physically present during the last 2 hours of labor prior to delivery.

Simply put, while the two involved obstetricians were in communication by phone with the nursing staff throughout labor (separately as their "shifts" did not overlap), no one actually came to the bedside and wrote a note) from admission until around 2 hours before delivery.

Medical staff bylaws call for a daily progress note; this bylaw was easily met.

In reviewing the case, it did not "feel good" that no one came to the bedside.

My questions:

1. Does anyone have or know of any guidelines to mandate such bedside attendance? Of course, we all hope that the involved physicians would not need said guidelines.
2. Does anyone have a suggestion of hospital/nursing protocols? Simply, in this case I would like to have had a charge nurse or bedside nurse simply say, "Hey, no one has been by for a while. What's up?"

Garry
Medica Forums - 6/1/13
Reviews Of Progress is a weekly peer-reviewed scientific journal that covers original research and reviews. It publishes all articles under the guidance of the editorial team. The current Editor-in-Chief is Pindipol S.I, the editorial office is in Solapur.
Medica Forums - 5/27/13
I helped another physician with removal of a retained placenta last night, we were unsuccessful in removing it vaginally, her cervix was too closed to allow manual removal and we could only get a few pieces out with ring forceps and a large curette, so we did a laparotomy/hysterotomy and were able to preserve the uterus. The placenta turned out not to be an accreta and it was easily removed via that route through a low vertical incision on the uterus. Any thoughts on the appropriate CPT code would be appreciated. The patient came in through the ER five days after home delivery by her husband. She was severely anemic, rcvd 7 units of blood and is still quite ill and in the ICU but improving.

Ronald E. Ainsworth, MD, FACOG
Medica Forums - 5/23/13
Hello,

Has anyone tried FetalGrowth app (App Store for iPhone/iPad) ? I'm interested in using a simple and handy tool to calculate fetal percentiles, and I came across this app, which seems it does the job (plots growth charts, as well). I haven't seen anything else, besides this app, so I was wondering if there are people who have already tried it.

Thanks !
Medica Forums - 5/19/13
Had a case the other day with the above finding on a pap. She was age 36 and had a Mirena in place. How do people feel about the idea of trying to do an EMB with an IUD in place? If not, how do we proceed?
Medica Forums - 5/12/13
Welcome to the new ObGyn.net Forum!

To all the members of OB-GYN-L… Thank you for coming! I’m thrilled that you’ve decided to check out the new Forum site, and look forward to reading about what’s on your mind.

If you’re new to the ObGyn.net community... welcome aboard! You’ve just joined an outstanding group of physicians and health care professionals who have been sharing information, answering questions, and building professional relationships via the site’s listserv for nearly 20 years.

Feel free to poke around on the site to get a feel for things, or take a look at the Help Topics page for instructions on how to use the different features of the site.

A few quick tips:
For those of you who like getting new Forum messages delivered directly to your inbox, the first thing you’ll want to do is click on the ‘Follow this forum’ button on the main page. You’ll have the option of getting notifications immediately, as a daily digest, a weekly digest, or only when you’re not online (which is to say, if you’re on the site when someone posts a message, you won’t be notified of it). You won’t be able to post on the site just by replying to the email, but the message will contain a link that takes you directly to the message you’d like to reply to.

You can also follow individual conversations without following the whole list by going into the topic and clicking the ‘Follow this topic’ button next to the title.

Also, in ‘My Profile’ you can:
  • Enter your professional information, including specialty, subspecialty, and education (by clicking ‘Edit my profile’)
  • See your activity on the Forum, such as what discussions you have initiated or replied to, content you’ve ‘liked,’ and activity of people you’ve made your friends
In ‘My Settings’ you can:
  • Add or change your photo
  • Edit your birthday, gender, interests, location
  • Create a signature for your posts
  • Change the types of content you get notifications for, or change the way you receive notifications
If you have questions, feel free to respond to this post or send me a direct message by clicking on the envelope icon.

Happy posting!

EducationalTutorials


Educational Tutorial: Complications of Laparoscopy
February 7, 2012

There are a variety of complications that can occur during laparoscopic surgery. In this tutorial learn some of the complications and tips to avoid them.

Educational Tutorial: Low Molecular Weight Heparin in Recurrent Abortions
January 17, 2012

Review information on low molecular weight heparin in recurrent miscarriages in this educational tutorial.

FromPhysiciansPractice

Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.